Piloting a Biofeedback Intervention for Adolescents With Overweight and a History of Adverse Childhood Experiences

Sponsor
Colorado State University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05984043
Collaborator
Children's Hospital Colorado (Other), University of Colorado, Denver (Other)
35
2
20

Study Details

Study Description

Brief Summary

Adverse childhood experiences (ACEs), referring to traumatic experiences occurring before 18 years of age (e.g., abuse/neglect), are associated with a 30-70% increased risk of developing adolescent and adult obesity and obesity-related cardiometabolic comorbidities, which may be due to dysregulation in stress-related physiology and engagement in stress-related behaviors. While adolescents with ACEs have a 2.25 times increased risk of obesity, standard-of-care lifestyle (e.g., nutrition/physical activity) interventions do not typically incorporate trauma-informed care, including assessment and therapeutic attention to effects of ACEs. Heart rate variability (HRV) biofeedback is an evidence-based, relatively brief, mind-body intervention targeting the stress physiology that can be dysregulated in adolescents with ACEs. The objective of this proposal is to adapt and test a 4-session HRV biofeedback protocol for 12-17-year-olds with BMI>85th percentile and ACEs. First (Phase 1), we will iteratively adapt a 4-session HRV biofeedback facilitator protocol with n=3-5 adolescents with overweight/obesity and ACEs, using adolescent quantitative and qualitative feedback to hone and optimize HRV biofeedback for this population (Aim 1). Next (Phase 2), we will conduct a randomized waitlist-controlled pilot study of n=30 adolescents with overweight/obesity and ACEs to assess acceptability and feasibility (Aim 2) and to describe changes in theorized targets of biofeedback (Aim 3).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Biofeedback
  • Other: Waitlist
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
35 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Piloting a Biofeedback Intervention for Adolescents With Overweight and a History of Adverse Childhood Experiences
Anticipated Study Start Date :
Nov 1, 2023
Anticipated Primary Completion Date :
Jul 1, 2025
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Biofeedback

Behavioral: Biofeedback
Heart-rate Variability Biofeedback

Other: Waitlist

Other: Waitlist
Waitlist control group

Outcome Measures

Primary Outcome Measures

  1. Facilitator Protocol [Year 1]

    4-session biofeedback facilitator protocol

  2. Feasibility/Acceptability [Year 1]

    Protocol implementation will be feasible in terms of recruitment (≥60% eligible enroll), intervention adherence (≥80% will receive >80% dosage), baseline/post-treatment assessment adherence (<20% missing data), and post-treatment retention (≥80%). Biofeedback will be acceptable based on session likeability ratings (80% >4:5) and qualitative themes assessed by interview indicative of likeability/benefit.

  3. Stress Physiology [Year 2]

  4. Stress Eating [Year 2]

  5. Inflammatory Biomarkers [Year 2]

  6. Insulin Sensitivity [Year 2]

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Four or more ACEs

  • BMI at or above the 85th percentile;

Exclusion Criteria:
  • Major renal, hepatic, endocrinologic, rheumatologic, cardiac, or pulmonary medical problem likely to affect mood or weight

  • Medications affecting mood or weight (e.g. anti-anxiety/depressants/psychotics, stimulants, mood stabilizers, insulin sensitizers, weight loss)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Colorado State University
  • Children's Hospital Colorado
  • University of Colorado, Denver

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elizabeth Ruzicka, Postdoctoral Fellow, Colorado State University
ClinicalTrials.gov Identifier:
NCT05984043
Other Study ID Numbers:
  • 5P30DK048520-29
First Posted:
Aug 9, 2023
Last Update Posted:
Aug 9, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 9, 2023